HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xiaoyang Qi Selected Research

Xiaoyang Qi Research Topics

Disease

32Neoplasms (Cancer)
05/2022 - 01/2004
8Brain Neoplasms (Brain Tumor)
11/2021 - 08/2013
6Glioblastoma (Glioblastoma Multiforme)
11/2021 - 08/2014
5Pancreatic Neoplasms (Pancreatic Cancer)
06/2021 - 01/2013
3Glioma (Gliomas)
01/2021 - 04/2015
3Adenocarcinoma
01/2020 - 01/2014
3Breast Neoplasms (Breast Cancer)
11/2019 - 09/2009
2Obesity
04/2022 - 01/2022
2Stomach Neoplasms (Stomach Cancer)
02/2022 - 01/2022
2Wounds and Injuries (Trauma)
01/2020 - 01/2017
2Neuroblastoma
04/2015 - 09/2009
1Carcinogenesis
05/2022
1Body Weight (Weight, Body)
01/2022
1Type 2 Diabetes Mellitus (MODY)
01/2022
1Colitis
04/2021
1Gaucher Disease (Gaucher's Disease)
05/2020
1Lysosomal Storage Diseases (Lysosomal Storage Disease)
05/2020
1Neoplasm Metastasis (Metastasis)
11/2019
1Primitive Neuroectodermal Tumors (PNET)
11/2017
1Neuroendocrine Tumors (Neuroendocrine Tumor)
11/2017
1Fibrosis (Cirrhosis)
11/2017
1Disease Progression
11/2017
1Carcinoid Tumor (Carcinoid)
11/2017
1Infections
01/2017
1Distal Femoral Fractures
01/2017
1Fibula Fractures
01/2017
1Sickle Cell Anemia (Hemoglobin S Disease)
11/2015
1Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar)
09/2015

Drug/Important Bio-Agent (IBA)

19PhosphatidylserinesIBA
05/2022 - 01/2012
17SaposinsIBA
05/2022 - 09/2009
9Proteins (Proteins, Gene)FDA Link
11/2021 - 09/2009
7Phospholipids (Phosphatides)FDA LinkGeneric
02/2015 - 10/2011
6Biomarkers (Surrogate Marker)IBA
05/2022 - 01/2013
6LipidsIBA
11/2021 - 01/2004
5Pharmaceutical PreparationsIBA
11/2021 - 04/2015
3Messenger RNA (mRNA)IBA
02/2022 - 01/2014
3RNA (Ribonucleic Acid)IBA
01/2022 - 11/2017
3Tumor Biomarkers (Tumor Markers)IBA
06/2021 - 04/2015
2CalciumIBA
05/2022 - 10/2015
2MicroRNAs (MicroRNA)IBA
02/2022 - 04/2021
2Temozolomide (Temodar)FDA LinkGeneric
11/2021 - 02/2017
2EnzymesIBA
05/2020 - 09/2009
2Fluorescent Dyes (Fluorescent Probes)IBA
10/2016 - 10/2011
2Thromboplastin (Tissue Factor)IBA
05/2016 - 01/2014
2CaspasesIBA
04/2015 - 09/2009
2Contrast MediaIBA
04/2015 - 10/2011
1bavituximabIBA
05/2022
1Monoclonal AntibodiesIBA
05/2022
1Circular RNAIBA
02/2022
1AntralIBA
01/2022
1Glucose (Dextrose)FDA LinkGeneric
01/2022
1Liposomes (Liposome)IBA
11/2021
1Sulfonic AcidsIBA
04/2021
1Benzene (Benzole)IBA
04/2021
1VaccinesIBA
01/2021
1Fatty Acids (Saturated Fatty Acids)IBA
01/2021
1Deoxyglucose (2 Deoxy D glucose)IBA
01/2021
1Mechanistic Target of Rapamycin Complex 1IBA
01/2021
1Adenosine Triphosphate (ATP)IBA
01/2021
1AcidsIBA
05/2020
1GlucosidasesIBA
05/2020
1GemcitabineFDA Link
01/2020
1Albumin-Bound PaclitaxelFDA Link
01/2020
1chondroitin 4-sulfotransferaseIBA
11/2019
1GlycosaminoglycansIBA
11/2019
1Long Noncoding RNAIBA
11/2019
1graphene oxideIBA
03/2019
1Peroxidase (Myeloperoxidase)IBA
03/2019
1Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric
03/2019
1Reactive Oxygen Species (Oxygen Radicals)IBA
03/2019
1Quinine (Quinson)FDA Link
03/2019
1Hydroxyl RadicalIBA
03/2019
1Dopamine (Intropin)FDA LinkGeneric
03/2019
1Phosphotransferases (Kinase)IBA
11/2017
1EverolimusFDA Link
11/2017
1Sirolimus (Rapamycin)FDA Link
11/2017
1CC-223IBA
11/2017
1MTOR InhibitorsIBA
11/2017
1Alkylating AgentsIBA
02/2017
1DNA (Deoxyribonucleic Acid)IBA
02/2017
1Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA
02/2017
1BI 2536IBA
02/2017
1Anti-Bacterial Agents (Antibiotics)IBA
01/2017
1Indicators and Reagents (Reagents)IBA
10/2016
1Coloring Agents (Dyes)IBA
10/2016
1Iodine-125IBA
05/2016
1IodineIBA
05/2016
1IntegrinsIBA
05/2016
1ProgranulinsIBA
09/2015

Therapy/Procedure

20Therapeutics
05/2022 - 10/2011
3Drug Therapy (Chemotherapy)
01/2022 - 04/2015
2Gastrectomy
04/2022 - 01/2022
1Glycemic Control
01/2022
1Radiotherapy
11/2021
1Enzyme Replacement Therapy
05/2020
1Biological Therapy
01/2020
1Debridement
01/2017
1Arthrodesis
01/2017
1Surgical Amputation (Amputations)
01/2017
1Internal Fixators
01/2017